MiT family translocation renal cell carcinoma

P Argani - Seminars in diagnostic pathology, 2015 - Elsevier
The MiT subfamily of transcription factors includes TFE3, TFEB, TFC, and MiTF. Gene
fusions involving two of these transcription factors have been identified in renal cell …

Immunohistochemical diagnosis of renal neoplasms

LD Truong, SS Shen - Archives of pathology & laboratory …, 2011 - meridian.allenpress.com
Context—Histologic diagnosis of renal neoplasm is usually straightforward by routine light
microscopy. However, immunomarkers may be essential in several contexts, including …

The International Society of Urological Pathology (ISUP) vancouver classification of renal neoplasia

JR Srigley, B Delahunt, JN Eble, L Egevad… - The American journal …, 2013 - journals.lww.com
The classification working group of the International Society of Urological Pathology
consensus conference on renal neoplasia was in charge of making recommendations …

[HTML][HTML] Distribution of metastatic sites in renal cell carcinoma: a population-based analysis

M Bianchi, M Sun, C Jeldres, SF Shariat, QD Trinh… - Annals of …, 2012 - Elsevier
Background We assessed the distribution of site-specific metastases in patients with renal
cell carcinoma (RCC) according to age. Moreover, we evaluated recommendations …

Proteogenomic characterization of MiT family translocation renal cell carcinoma

Y Qu, X Wu, A Anwaier, J Feng, W Xu, X Pei… - Nature …, 2022 - nature.com
Microphthalmia transcription factor (MiT) family translocation renal cell carcinoma (tRCC) is
a rare type of kidney cancer, which is not well characterized. Here we show the …

MiT family translocation renal cell carcinoma: from the early descriptions to the current knowledge

A Caliò, D Segala, E Munari, M Brunelli, G Martignoni - Cancers, 2019 - mdpi.com
The new category of MiT family translocation renal cell carcinoma has been included into
the World Health Organization (WHO) classification in 2016. The MiT family translocation …

Adult Xp11 translocation renal cell carcinoma diagnosed by cytogenetics and immunohistochemistry

Y Komai, M Fujiwara, Y Fujii, H Mukai, J Yonese… - Clinical Cancer …, 2009 - AACR
Purpose: To determine the incidence of Xp11 translocation renal cell carcinoma (RCC) in
adult patients using cytogenetics and immunohistochemstry. Experimental Design …

Xp11 translocation renal cell carcinoma (RCC): extended immunohistochemical profile emphasizing novel RCC markers

P Argani, J Hicks, AM De Marzo… - The American journal …, 2010 - journals.lww.com
Xp11 translocation renal cell carcinoma (RCC) harbor various TFE3 gene fusions, and are
known to underexpress epithelial immunohistochemical (IHC) markers such as cytokeratin …

Renal translocation carcinomas: clinicopathologic, immunohistochemical, and gene expression profiling analysis of 31 cases with a review of the literature

P Camparo, V Vasiliu, V Molinie… - The American journal …, 2008 - journals.lww.com
We report clinicopathologic features of a large series of renal translocation carcinomas from
a multicentric study. Diagnosis was performed by cytogenetic examination of fresh material …

TFE3 rearrangements in adult renal cell carcinoma: clinical and pathologic features with outcome in a large series of consecutively treated patients

WR Sukov, JC Hodge, CM Lohse… - The American journal …, 2012 - journals.lww.com
Renal cell carcinoma (RCC) with chromosomal rearrangement of transcription factor for
immunoglobulin heavy-chain enhancer 3 (TFE3) at Xp11. 2 is a distinct subtype that was …